Multicenter safety study of mFOLFOX6 for unresectable advanced/recurrent colorectal cancer in elderly patients

BACKGROUND: Combination chemotherapy with oxaliplatin plus 5-fluorouracil/leucovorin (FOLFOX) has become a standard regimen for colorectal cancer. An increase of adverse events with combination chemotherapy is predicted in elderly patients, and it remains controversial whether they should receive th...

Descripción completa

Detalles Bibliográficos
Autores principales: Sugimoto, Shinichi, Katano, Kuniyuki, Kanazawa, Akiyoshi, Yoshimura, Hiroshi, Kidani, Akihiko, Takeda, Hiroshi, Makino, Masato, Ozaki, Nobuhiro, Tanaka, Tsuneo, Ikeguchi, Masahide
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2731734/
https://www.ncbi.nlm.nih.gov/pubmed/19664225
http://dx.doi.org/10.1186/1756-9966-28-109

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2731734/
https://www.ncbi.nlm.nih.gov/pubmed/19664225
http://dx.doi.org/10.1186/1756-9966-28-109

Ejemplares similares